$CEMP News
Last published 6y ago
- 6y agoCEMPMelinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive OfficerGlobeNewswireMORRISTOWN, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage company focused on the development and commercialization of novel antibiotics, today...
- 8y agoHTGCWFCQTRXAQ+7Hercules Capital Announces Fourth Quarter and Full-Year 2017 Financial Results and Quarterly Distribution of $0.31 per ShareBusiness WirePALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the fourth quarter and fiscal-year ended December 31, 2017.
- 8y agoHTGCQTRXAQFSCT+7Hercules Capital Achieves More Than $880 Million in New Commitments in 2017(1)Business WirePALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced its portfolio update for the fourth quarter and full-year 2017.
- 9y agoHTGCWFCFSCTCEMP+2Hercules Announces Third Quarter 2017 Financial Results and Declares a $0.31 per Share Quarterly DistributionBusiness WirePALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the third quarter ended September 30, 2017.
- 9y agoHTGCCEMPAVEOINSM+1Hercules Capital Provides Interim Portfolio Update for Q3 2017Business WirePALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced its interim portfolio update for the third quarter 2017.
- 9y agoCEMPMalin Investee Company - Melinta Therapeutics - To Be Transformed into a NASDAQ Listed CompanyBusiness WireDUBLIN--(BUSINESS WIRE)--Malin Corporation plc. (ISE:MLC, "Malin"), an Irish based and globally operating life sciences company, today announced that Melinta Therapeutics, Inc. (“Melinta”), a Malin investee company focused on discovering, developing, and commercialising novel antibiotics to treat serious bacterial infections, has entered into a definitive agreement with Cempra, Inc. (Nasdaq:CEMP, ...
- 9y agoCEMPCempra's (CEMP) CEO David Zaccardelli on Q4 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoCEMPCempra's (CEMP) CEO Prabha Fernandes Presents at Baird Global Healthcare Conference (Transcript)Earnings Call Transcripts
- 10y agoCEMPCempra's (CEMP) CEO Prabhavathi Fernandes on Q1 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoCEMPCempra (CEMP) CEO Dr. Prabha Fernandes on Q4 2015 Results - Earnings Call TranscriptEarnings Call Transcripts